Structural modeling of cytokine-receptor-JAK2 signaling complexes using AlphaFold Multimer

Homodimeric class 1 cytokine receptors include the erythropoietin (EPOR), thrombopoietin (TPOR), granulocyte colony-stimulating factor 3 (CSF3R), growth hormone (GHR), and prolactin receptors (PRLR). They are cell-surface single-pass transmembrane (TM) glycoproteins that regulate cell growth, proliferation, and differentiation and induce oncogenesis. An active TM signaling complex consists of a receptor homodimer, one or two ligands bound to the receptor extracellular domains and two molecules of Janus Kinase 2 (JAK2) constitutively associated with the receptor intracellular domains. Although crystal structures of soluble extracellular domains with ligands have been obtained for all the receptors except TPOR, little is known about the structure and dynamics of the complete TM complexes that activate the downstream JAK-STAT signaling pathway. Three-dimensional models of five human receptor complexes with cytokines and JAK2 were generated using AlphaFold Multimer. Given the large size of the complexes (from 3220 to 4074 residues), the modeling required a stepwise assembly from smaller parts with selection and validation of the models through comparisons with published experimental data. The modeling of active and inactive complexes supports a general activation mechanism that involves ligand binding to a monomeric receptor followed by receptor dimerization and rotational movement of the receptor TM α-helices causing proximity, dimerization, and activation of associated JAK2 subunits. The binding mode of two eltrombopag molecules to TM α-helices of the active TPOR dimer was proposed. The models also help elucidating the molecular basis of oncogenic mutations that may involve non-canonical activation route. Models equilibrated in explicit lipids of the plasma membrane are publicly available.

[1]  Xiaorong Liu,et al.  pyCHARMM: Embedding CHARMM Functionality in a Python Framework. , 2023, Journal of chemical theory and computation.

[2]  K. Lindorff-Larsen,et al.  The prolactin receptor scaffolds Janus kinase 2 via co-structure formation with phosphoinositide-4,5-bisphosphate , 2023, bioRxiv.

[3]  G. Mazzucchelli,et al.  Oncogenic CALR mutant C-terminus mediates dual binding to the thrombopoietin receptor triggering complex dimerization and activation , 2023, Nature Communications.

[4]  I. Pogozheva,et al.  Effects of calreticulin mutations on cell transformation and immunity , 2023, Journal of cellular and molecular medicine.

[5]  S. Hubbard,et al.  Structural basis of Janus kinase trans-activation , 2023, Cell reports.

[6]  Nathan R. Kern,et al.  CHARMM-GUI PDB Manipulator: Various PDB Structural Modifications for Biomolecular Modeling and Simulation. , 2023, Journal of molecular biology.

[7]  J. Tavernier,et al.  Mechanism of receptor assembly via the pleiotropic adipokine Leptin , 2022, bioRxiv.

[8]  Cathy H. Wu,et al.  UniProt: the Universal Protein Knowledgebase in 2023 , 2022, Nucleic Acids Res..

[9]  C. Deane,et al.  Membranome 3.0: Database of single‐pass membrane proteins with AlphaFold models , 2022, Protein science : a publication of the Protein Society.

[10]  A. Pyle,et al.  US-align: universal structure alignments of proteins, nucleic acids, and macromolecular complexes , 2022, Nature Methods.

[11]  Jerry M. Parks,et al.  AF2Complex predicts direct physical interactions in multimeric proteins with deep learning , 2022, Nature Communications.

[12]  P. Lupardus,et al.  Structure of a Janus kinase cytokine receptor complex reveals the basis for dimeric activation , 2022, Science.

[13]  W. Im,et al.  Comparative Molecular Dynamics Simulation Studies of Realistic Eukaryotic, Prokaryotic, and Archaeal Membranes , 2022, J. Chem. Inf. Model..

[14]  G. Lukács,et al.  Ins and outs of AlphaFold2 transmembrane protein structure predictions , 2022, Cellular and molecular life sciences : CMLS.

[15]  D. Hassabis,et al.  AlphaFold Protein Structure Database: massively expanding the structural coverage of protein-sequence space with high-accuracy models , 2021, Nucleic Acids Res..

[16]  I. Rapado,et al.  MPL S505C enhances driver mutations at W515 in essential thrombocythemia , 2021, Blood Cancer Journal.

[17]  A. Lomize,et al.  Spatial arrangement of proteins in planar and curved membranes by PPM 3.0 , 2021, Protein science : a publication of the Protein Society.

[18]  Brandon Yushan Feng,et al.  Benchmarking AlphaFold for protein complex modeling reveals accuracy determinants , 2021, bioRxiv.

[19]  D. Hassabis,et al.  Protein complex prediction with AlphaFold-Multimer , 2021, bioRxiv.

[20]  Douglas E. V. Pires,et al.  A structural biology community assessment of AlphaFold2 applications , 2021, bioRxiv.

[21]  A. Elofsson,et al.  Improved prediction of protein-protein interactions using AlphaFold2 and extended multiple-sequence alignments , 2021, bioRxiv.

[22]  J. Pei,et al.  Human mitochondrial protein complexes revealed by large-scale coevolution analysis and deep learning-based structure modeling , 2021, bioRxiv.

[23]  S. Ovchinnikov,et al.  ColabFold: making protein folding accessible to all , 2022, Nature Methods.

[24]  K. Kavukcuoglu,et al.  Highly accurate protein structure prediction for the human proteome , 2021, Nature.

[25]  Oriol Vinyals,et al.  Highly accurate protein structure prediction with AlphaFold , 2021, Nature.

[26]  J. Tucker,et al.  The thrombopoietin receptor: revisiting the master regulator of platelet production , 2021, Platelets.

[27]  W. Vainchenker,et al.  Functional Consequences of Mutations in Myeloproliferative Neoplasms , 2021, HemaSphere.

[28]  G. Hassink,et al.  Growth Hormone Receptor Regulation in Cancer and Chronic Diseases , 2020, Frontiers in Endocrinology.

[29]  S. Hubbard,et al.  Mechanism of homodimeric cytokine receptor activation and dysregulation by oncogenic mutations , 2020, Science.

[30]  S. Carillo,et al.  MPL Mutations in Essential Thrombocythemia Uncover A Common Path of Activation with Eltrombopag Dependent on W491. , 2020, Blood.

[31]  S. Hubbard,et al.  Structural models of full-length JAK2 kinase , 2019, bioRxiv.

[32]  D. Vertommen,et al.  Calreticulin mutants as oncogenic rogue chaperones for TpoR and traffic-defective pathogenic TpoR mutants. , 2019, Blood.

[33]  J. Scheller,et al.  Naturally occurring and synthetic constitutive-active cytokine receptors in disease and therapy. , 2019, Cytokine & growth factor reviews.

[34]  O. Silvennoinen,et al.  The regulation of JAKs in cytokine signaling and its breakdown in disease. , 2019, Cytokine.

[35]  W. Vainchenker,et al.  The role of the thrombopoietin receptor MPL in myeloproliferative neoplasms: recent findings and potential therapeutic applications , 2019, Expert review of hematology.

[36]  M. Nguyen,et al.  Structural Investigation of Human Prolactin Receptor Transmembrane Domain Homodimerization in a Membrane Environment through Multiscale Simulations. , 2019, The journal of physical chemistry. B.

[37]  J. Babon,et al.  The molecular details of cytokine signaling via the JAK/STAT pathway , 2018, Protein science : a publication of the Protein Society.

[38]  H. Wallweber,et al.  Receptor-mediated dimerization of JAK2 FERM domains is required for JAK2 activation , 2018, eLife.

[39]  O. Bocharova,et al.  Structural basis of the signal transduction via transmembrane domain of the human growth hormone receptor. , 2018, Biochimica et biophysica acta. General subjects.

[40]  J. Tyner,et al.  Gain-of-function mutations in granulocyte colony–stimulating factor receptor (CSF3R) reveal distinct mechanisms of CSF3R activation , 2018, The Journal of Biological Chemistry.

[41]  A. Brooks,et al.  The Growth Hormone Receptor: Mechanism of Receptor Activation, Cell Signaling, and Physiological Aspects , 2018, Front. Endocrinol..

[42]  W. Vainchenker,et al.  Genetic Alterations of the Thrombopoietin/MPL/JAK2 Axis Impacting Megakaryopoiesis , 2017, Front. Endocrinol..

[43]  P. Lupardus,et al.  The Janus Kinase (JAK) FERM and SH2 Domains: Bringing Specificity to JAK–Receptor Interactions , 2017, Front. Endocrinol..

[44]  C. Pecquet,et al.  The Thrombopoietin Receptor: Structural Basis of Traffic and Activation by Ligand, Mutations, Agonists, and Mutated Calreticulin , 2017, Front. Endocrinol..

[45]  Andrei L Lomize,et al.  TMDOCK: An Energy-Based Method for Modeling α-Helical Dimers in Membranes. , 2017, Journal of molecular biology.

[46]  Vijay S. Pande,et al.  OpenMM 7: Rapid development of high performance algorithms for molecular dynamics , 2016, bioRxiv.

[47]  B. L. de Groot,et al.  CHARMM36m: an improved force field for folded and intrinsically disordered proteins , 2016, Nature Methods.

[48]  Clifford Liongue,et al.  Evolution of Cytokine Receptor Signaling , 2016, The Journal of Immunology.

[49]  C. Pecquet,et al.  Oncogenic activation of MPL/thrombopoietin receptor by 17 mutations at W515: implications for myeloproliferative neoplasms , 2016, Leukemia.

[50]  S. Constantinescu,et al.  His499 Regulates Dimerization and Prevents Oncogenic Activation by Asparagine Mutations of the Human Thrombopoietin Receptor* , 2015, The Journal of Biological Chemistry.

[51]  Alexander D. MacKerell,et al.  CHARMM-GUI Input Generator for NAMD, GROMACS, AMBER, OpenMM, and CHARMM/OpenMM Simulations Using the CHARMM36 Additive Force Field , 2015, Journal of chemical theory and computation.

[52]  Qingxin Li,et al.  Solution structure of the transmembrane domain of the mouse erythropoietin receptor in detergent micelles , 2015, Scientific Reports.

[53]  M. Waters,et al.  Intrinsically disordered cytoplasmic domains of two cytokine receptors mediate conserved interactions with membranes. , 2015, The Biochemical journal.

[54]  A. Roitberg,et al.  Long-Time-Step Molecular Dynamics through Hydrogen Mass Repartitioning. , 2015, Journal of chemical theory and computation.

[55]  M. Waters,et al.  JAK2 activation by growth hormone and other cytokines , 2015, The Biochemical journal.

[56]  Sunhwan Jo,et al.  CHARMM‐GUI Membrane Builder toward realistic biological membrane simulations , 2014, J. Comput. Chem..

[57]  J. Olsen,et al.  Who climbs the tryptophan ladder? On the structure and function of the WSXWS motif in cytokine receptors and thrombospondin repeats. , 2014, Cytokine & growth factor reviews.

[58]  Adam R. Johnson,et al.  Structure of the pseudokinase–kinase domains from protein kinase TYK2 reveals a mechanism for Janus kinase (JAK) autoinhibition , 2014, Proceedings of the National Academy of Sciences.

[59]  Guillermo A. Gomez,et al.  Mechanism of Activation of Protein Kinase JAK2 by the Growth Hormone Receptor , 2014, Science.

[60]  W. Alexander,et al.  Functional characterization of c-Mpl ectodomain mutations that underlie congenital amegakaryocytic thrombocytopenia , 2014, Growth factors.

[61]  Marco Biasini,et al.  lDDT: a local superposition-free score for comparing protein structures and models using distance difference tests , 2013, Bioinform..

[62]  C. Pecquet,et al.  Tryptophan at the transmembrane–cytosolic junction modulates thrombopoietin receptor dimerization and activation , 2013, Proceedings of the National Academy of Sciences.

[63]  Adrian Whitty,et al.  Understanding cytokine and growth factor receptor activation mechanisms , 2012, Critical reviews in biochemistry and molecular biology.

[64]  L. Johnson,et al.  The structural basis for control of eukaryotic protein kinases. , 2012, Annual review of biochemistry.

[65]  C. Brooks Molecular mechanisms of prolactin and its receptor. , 2012, Endocrine reviews.

[66]  C. Pecquet,et al.  Orientation‐specific signalling by thrombopoietin receptor dimers , 2011, The EMBO journal.

[67]  Wei Liu,et al.  Functional impact of manipulation on the relative orientation of human prolactin receptor domains. , 2011, Biochemistry.

[68]  D. Engelman,et al.  Thrombopoietin receptor activation: transmembrane helix dimerization, rotation, and allosteric modulation , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[69]  Patrick England,et al.  Structural characterization of the stem-stem dimerization interface between prolactin receptor chains complexed with the natural hormone. , 2010, Journal of molecular biology.

[70]  V. Goffin,et al.  New concepts in prolactin biology. , 2010, The Journal of endocrinology.

[71]  Bo Yu,et al.  Identification of the Residues in the Extracellular Domain of Thrombopoietin Receptor Involved in the Binding of Thrombopoietin and a Nuclear Distribution Protein (Human NUDC)* , 2010, The Journal of Biological Chemistry.

[72]  Alan E Mark,et al.  Turning the growth hormone receptor on: Evidence that hormone binding induces subunit rotation , 2010, Proteins.

[73]  S. Iida,et al.  The Asn505 mutation of the c-MPL gene, which causes familial essential thrombocythemia, induces autonomous homodimerization of the c-Mpl protein due to strong amino acid polarity. , 2009, Blood.

[74]  Jianpeng Ma,et al.  CHARMM: The biomolecular simulation program , 2009, J. Comput. Chem..

[75]  Jeffery B. Klauda,et al.  CHARMM-GUI Membrane Builder for mixed bilayers and its application to yeast membranes. , 2009, Biophysical journal.

[76]  Taehoon Kim,et al.  CHARMM‐GUI: A web‐based graphical user interface for CHARMM , 2008, J. Comput. Chem..

[77]  A. Walker,et al.  S2 deletion variants of human PRL receptors demonstrate that extracellular domain conformation can alter conformation of the intracellular signaling domain. , 2008, Biochemistry.

[78]  W. Im,et al.  Automated Builder and Database of Protein/Membrane Complexes for Molecular Dynamics Simulations , 2007, PloS one.

[79]  D. Levy,et al.  JAK-STAT Signaling: From Interferons to Cytokines* , 2007, Journal of Biological Chemistry.

[80]  S. Opella,et al.  NMR Structural Studies of Interactions of a Small, Nonpeptidyl Tpo Mimic with the Thrombopoietin Receptor Extracellular Juxtamembrane and Transmembrane Domains* , 2007, Journal of Biological Chemistry.

[81]  Harvey F. Lodish,et al.  The Membrane-proximal Region of the Thrombopoietin Receptor Confers Its High Surface Expression by JAK2-dependent and -independent Mechanisms* , 2006, Journal of Biological Chemistry.

[82]  S. Gadd,et al.  Ligand-independent dimerization of the human prolactin receptor isoforms: functional implications. , 2006, Molecular endocrinology.

[83]  H. Lodish,et al.  Active Conformation of the Erythropoietin Receptor , 2006, Journal of Biological Chemistry.

[84]  T. Okamoto,et al.  Homodimeric cross-over structure of the human granulocyte colony-stimulating factor (GCSF) receptor signaling complex. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[85]  Michael W Parker,et al.  Model for growth hormone receptor activation based on subunit rotation within a receptor dimer , 2005, Nature Structural &Molecular Biology.

[86]  S. Constantinescu,et al.  Structural Requirements of the Extracellular to Transmembrane Domain Junction for Erythropoietin Receptor Function* , 2005, Journal of Biological Chemistry.

[87]  P. Campbell,et al.  Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders , 2005, The Lancet.

[88]  K Henrick,et al.  Electronic Reprint Biological Crystallography Secondary-structure Matching (ssm), a New Tool for Fast Protein Structure Alignment in Three Dimensions Biological Crystallography Secondary-structure Matching (ssm), a New Tool for Fast Protein Structure Alignment in Three Dimensions , 2022 .

[89]  J. Skolnick,et al.  Scoring function for automated assessment of protein structure template quality , 2004, Proteins.

[90]  Michael Feig,et al.  MMTSB Tool Set: enhanced sampling and multiscale modeling methods for applications in structural biology. , 2004, Journal of molecular graphics & modelling.

[91]  S. Constantinescu,et al.  Active and inactive orientations of the transmembrane and cytosolic domains of the erythropoietin receptor dimer. , 2003, Molecular cell.

[92]  A. Kossiakoff,et al.  Site2 binding energetics of the regulatory step of growth hormone–induced receptor homodimerization , 2003, Protein science : a publication of the Protein Society.

[93]  W. Paul,et al.  Molecular phylogeny within type I cytokines and their cognate receptors. , 2003, Immunity.

[94]  A. Pizzey,et al.  An activating mutation in the transmembrane domain of the granulocyte colony-stimulating factor receptor in patients with acute myeloid leukemia , 2002, Oncogene.

[95]  H. Lodish,et al.  Ligand-independent oligomerization of cell-surface erythropoietin receptor is mediated by the transmembrane domain , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[96]  H. Lodish,et al.  The erythropoietin receptor cytosolic juxtamembrane domain contains an essential, precisely oriented, hydrophobic motif. , 2001, Molecular cell.

[97]  Ursula Klingmüller,et al.  Self assembly of the transmembrane domain promotes signal transduction through the erythropoietin receptor , 2001, Current Biology.

[98]  A. Kossiakoff,et al.  Ternary complex between placental lactogen and the extracellular domain of the prolactin receptor , 2000, Nature Structural Biology.

[99]  M. Waters,et al.  Growth Hormone (GH)-independent Dimerization of GH Receptor by a Leucine Zipper Results in Constitutive Activation* , 2000, The Journal of Biological Chemistry.

[100]  V. Broudy,et al.  Deletion of the extracellular membrane-distal cytokine receptor homology module of Mpl results in constitutive cell growth and loss of thrombopoietin binding. , 1999, Blood.

[101]  S. Anderson,et al.  Constitutive Activation of the Prolactin Receptor Results in the Induction of Growth Factor-independent Proliferation and Constitutive Activation of Signaling Molecules* , 1999, The Journal of Biological Chemistry.

[102]  I. Wilson,et al.  Crystallographic evidence for preformed dimers of erythropoietin receptor before ligand activation. , 1999, Science.

[103]  Robert M. Stroud,et al.  Efficiency of signalling through cytokine receptors depends critically on receptor orientation , 1998, Nature.

[104]  T. Darden,et al.  A smooth particle mesh Ewald method , 1995 .

[105]  Bernard R. Brooks,et al.  New spherical‐cutoff methods for long‐range forces in macromolecular simulation , 1994, J. Comput. Chem..

[106]  Bernard R. Brooks,et al.  Solvent-Induced Forces between Two Hydrophilic Groups , 1994 .

[107]  H. Lodish,et al.  Homodimerization and constitutive activation of the erythropoietin receptor. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[108]  M. Ultsch,et al.  Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. , 1992, Science.

[109]  W. L. Jorgensen,et al.  Comparison of simple potential functions for simulating liquid water , 1983 .

[110]  G. Ciccotti,et al.  Numerical Integration of the Cartesian Equations of Motion of a System with Constraints: Molecular Dynamics of n-Alkanes , 1977 .

[111]  S. Watowich The Erythropoietin Receptor: Molecular Structure and Hematopoietic Signaling Pathways , 2011 .

[112]  B. Rost,et al.  Critical assessment of methods of protein structure prediction (CASP)—Round 6 , 2005, Proteins.